Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Antithrombotic Versus. Single antiPlatelet Therapy Following Left Atrial Appendage Closure：NAPT-LAAC Randomized Controlled Trial

NCT07125417 is registered in ClinicalTrials.gov with OCEAN-SHD Study Group as lead sponsor.

NCT NCT07125417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07125417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Antithrombotic Versus. Single antiPlatelet Therapy Following Left Atrial Appendage Closure：NAPT-LAAC Randomized Controlled Trial
Lead sponsor
OCEAN-SHD Study Group
Phase
Phase 4
Overall status
Recruiting
Start date
May 29, 2025
Completion date
March 31, 2030
Enrollment
500 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, high bleeding risk, left atrial appendage closure, non-antithrombotic therapy, nonvalvular atrial fibrillation